Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients.
Research Advances in Biomarkers for Demyelinating Optic Neuritis.
Cost of disorders of the brain in Spain.
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
The pathogenic role of the inflammasome in neurodegenerative diseases.
An analytical model for estimating water exchange rate in white matter using diffusion MRI.
Pilates exercise training vs. physical therapy for improving walking and balance in people with multiple sclerosis: A randomized controlled trial.
Human endogenous retroviruses and the nervous system.
The history of neuromyelitis optica.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Assisted reproduction technology in multiple sclerosis: Giving birth to a new avenue of research in hormones and autoimmunity.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
The induction of Treg cells by gut-indigenous Clostridium.
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.

Pages